Q-omics provides the consensus-scored MIR4795 profile across patient tissues and cancer cell-line models. MIR4795 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, MIR4795 is differentially expressed in 5, with the highest sampling consensus in THCA. Additionally, MIR4795 RNA expression shows 5,755 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight KIRP, THCA, and UCEC as cancer lineages where MIR4795 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4795 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4795 survival associations across molecular data types. MIR4795 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4795 RNA expression–survival associations across cancer types. High MIR4795 expression shows unfavorable associations in KIRP, ACC, KIRC, PAAD and UCEC, but favorable associations in READ. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRP as the clearest survival context for MIR4795 RNA expression.
This table summarizes MIR4795 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4795. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4795 shows lower tumor expression in THCA, COAD and KICH and higher tumor expression in STAD and LUAD. The THCA box plot shows higher MIR4795 RNA expression in normal versus tumor tissue (log2 FC = −0.496, t-test p < 0.001).
This table shows molecular features associated with MIR4795 in patient tissues and cancer cell lines. In patient samples, MIR4795 shows the broadest associations at the RNA and protein expression levels, with UCEC recurring as the lineage with the largest associated feature set.
